TOKYO, May 25 (Pulse News Wire) – Kohjin Bio CO.,LTD. (177A.T) announced today that its board of directors has resolved to propose amendments to the company's articles of incorporation at the upcoming 47th annual shareholders meeting scheduled for May 25, 2026.
The proposed changes aim to expand the scope of the company’s operations, enhance governance structures, and streamline decision-making processes. Specifically, the amendments include: - Expanding the company’s business activities to encompass biotechnology analysis services, cosmetic manufacturing, and medical device production.
- Transitioning to a dual CEO system consisting of a Chairman and President, necessitating revisions to provisions related to convening meetings and chairmanship roles. - Establishing a committee of audit and supervisory members to strengthen oversight functions and improve governance, while delegating authority to expedite decision-making and operational efficiency.
Additionally, the company plans to hold the shareholders' meeting on June 26, 2026 to finalize these changes, which will take effect immediately upon approval.
🟡 Confidence: Standard AI-translated content.